Your session is about to expire
← Back to Search
Behavioural Intervention
OPTIONS Program for Osteoporosis (OPTIONS Trial)
N/A
Waitlist Available
Led By Denise Orwig, PhD
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Aged 65 and over
Be older than 65 years old
Must not have
Not English or Spanish-speaking
Timeline
Screening 3 weeks
Treatment Varies
Follow Up six months and twelve months post-snf discharge (two-time points)
Awards & highlights
No Placebo-Only Group
Summary
"This trial aims to improve recovery and prevent future fractures in older adults who have broken a hip or leg. The researchers will implement a program called OsteoPorotic fracTure preventION System (
Who is the study for?
This trial is for older adults who have osteoporosis and have suffered a broken hip or leg. It aims to improve their recovery by testing a program called OPTIONS, which integrates exercise, diet, and bone-strengthening medication into post-fracture care in skilled nursing facilities (SNFs) and after discharge.
What is being tested?
The study compares the effectiveness of the OPTIONS program with enhanced usual care in SNFs. Enhanced usual care includes standard post-fracture treatment plus information on fall prevention. The goal is to see if OPTIONS can improve physical function and quality of life after discharge.
What are the potential side effects?
Since this trial focuses on implementing an integrated regimen of exercise, healthy diet, and medications rather than testing new drugs, side effects are not the primary concern but may include typical risks associated with any new exercise or dietary changes.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 65 years old or older.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I do not speak English or Spanish.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ discharge from a snf within four weeks and at six months and twelve months post-snf discharge (three-time points)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~discharge from a snf within four weeks and at six months and twelve months post-snf discharge (three-time points)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Patient-reported function
Patient-reported quality of life
Secondary study objectives
Care Partner Reported Mortality Rate
Number of patients with Falls
Number of patients with Fractures
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: OPTIONS interventionExperimental Treatment1 Intervention
OPTIONS is a multimodal intervention approach that includes providing clinical decision support (CDS) for healthcare providers, patients, and their caregivers focused on exercise, nutrition, and bone-enhancing medications using CDS in SNFs that use the same electronic health record system (PointClickCare).
Group II: Enhanced Usual CareActive Control1 Intervention
Enhanced usual care includes access to the STEADI (Stopping Elderly Accidents, Deaths, and Injuries) toolkit, a fall prevention program from the CDC.
Find a Location
Who is running the clinical trial?
Hebrew SeniorLifeOTHER
47 Previous Clinical Trials
270,749 Total Patients Enrolled
3 Trials studying Osteoporosis
4,029 Patients Enrolled for Osteoporosis
Brigham and Women's HospitalLead Sponsor
1,670 Previous Clinical Trials
11,876,713 Total Patients Enrolled
10 Trials studying Osteoporosis
90,536 Patients Enrolled for Osteoporosis
University of Maryland, BaltimoreOTHER
716 Previous Clinical Trials
379,556 Total Patients Enrolled
4 Trials studying Osteoporosis
1,700 Patients Enrolled for Osteoporosis
University of FloridaOTHER
1,409 Previous Clinical Trials
765,670 Total Patients Enrolled
1 Trials studying Osteoporosis
394 Patients Enrolled for Osteoporosis
Patient-Centered Outcomes Research InstituteOTHER
580 Previous Clinical Trials
27,103,706 Total Patients Enrolled
2 Trials studying Osteoporosis
6,414 Patients Enrolled for Osteoporosis
Denise Orwig, PhDPrincipal InvestigatorUniversity of Maryland, Baltimore
1 Previous Clinical Trials
10 Total Patients Enrolled
Patricia Dykes, RN, PhDPrincipal InvestigatorBrigham and Women's Hospital